Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
about
Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast CancerTargeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancerAnti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells.The nuclear receptor REV-ERBα represses the transcription of growth/differentiation factor 10 and 15 genes in rat endometrium stromal cells.Molecular Targets for Small-Molecule Modulators of Circadian Clocks.The functional and predictive roles of miR-210 in cryptorchidism.Autophagy inhibitors.Lysosomotropic REV-ERB antagonism: A metabolic connection between circadian rhythm and autophagy may tell cancer cells "it's time to die".Domain-Specific Monoclonal Antibodies Against Human Rev-erbβ.In Silico Study, Synthesis, and Cytotoxic Activities of Porphyrin Derivatives.Removal of Rev-erbα inhibition contributes to the prostaglandin G/H synthase 2 expression in rat endometrial stromal cells.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems.Autophagy is essential for maintaining the growth of a human (mini-)organ: Evidence from scalp hair follicle organ culture.Altered Circadian Rhythms and Breast Cancer: From the Human to the Molecular LevelDistinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle.A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy.
P2860
Q26795488-64A0FC0B-1E9F-4C65-955D-F1BBBE50022DQ33798788-D6291710-168F-4BA5-BBE1-5BA2E4204241Q35920724-F13A363F-039A-4556-8B5C-942BE54495D0Q36597665-AAB8CD51-7C3D-42AE-AD9D-B5C31F8F77FBQ36779787-0A961F3A-1B8C-4D86-933D-B5D0729477ABQ37209574-718F7FEA-79E3-48F8-A4EB-D24078283678Q38666985-7333C093-AAE0-4CC1-8035-5236338FEEA9Q41836829-6149DF84-5EEF-4CFD-BCBA-E86993C4761DQ45862973-F229F0EC-61C4-4143-BE15-F5073D731C21Q48044213-C7A16829-8DDA-49A5-82C2-0C2A8113506BQ48229393-403605F5-D579-4AED-AC32-3290CB060956Q49315568-5E06A22C-A09A-4F98-8782-DDC1C6093FF1Q51793703-8822B506-44B1-4053-A4A0-339A16170E06Q52625698-2E0F2564-423D-4641-8353-965319D984FDQ54157077-AC447AEB-4A97-4B5B-9016-35D5C5B81953Q55302787-96CCBF3A-5408-4F40-B83A-CD89A95F6AFCQ55645076-953B65AD-3B89-4D99-AEF2-35F6AEFF56E0
P2860
Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@ast
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@en
type
label
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@ast
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@en
prefLabel
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@ast
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@en
P2093
P2860
P50
P356
P1433
P1476
Dual inhibition of REV-ERBβ an ...... e cytotoxicity in cancer cells
@en
P2093
A Reggiani
C Lo Vecchio
E Torrente
R Scarpelli
P2860
P2888
P304
P356
10.1038/ONC.2014.203
P407
P577
2014-07-14T00:00:00Z